小米集團-W(01810.HK):美國法院頒發最終判決 解除美國國防部對公司中國軍方公司的認定
格隆匯5月26日丨小米集團-W(01810.HK)公佈,針對美國國防部於2021年1月14日將公司認定為中國軍方公司的事宜,公司很欣慰地宣佈,美東時間2021年5月25日下午4時09分,美國哥倫比亞特區地方法院頒發了最終判決,解除了美國國防部對於公司中國軍方公司的認定,正式撤銷了美國投資者購買或持有公司證券的全部限制。
公司表示,特此感謝全球用户、合作伙伴、員工、股東對小米的信任和支持。公司是一家開放、透明、股票公開交易、經營管理獨立的公司。公司將持之以恆,為用户提供值得信賴的消費電子產品與服務,堅持做感動人心、價格厚道的好產品,讓全球每個人都能享受科技帶來的美好生活。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.